Veradermics, Incorporated Common Stock (MANE)

SG&A Expense Growth

22.48%

Quarterly · Period ending:

MANE logo

MANE SG&A Expense Growth

Latest reported22.48%
MANE Quarterly SG&A Growth (QoQ) (0.00% → 22.48%)
High-resolution chart · PNG

MANE sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Veradermics, Incorporated Common Stock SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
22.4796%
85.4534%
114.0826%
29.0711%
18.8011%
43.7806%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.